156 related articles for article (PubMed ID: 34781282)
1. Peritoneal Expression of SGLT-2, GLUT1, and GLUT3 in Peritoneal Dialysis Patients.
Schricker S; Oberacker T; Fritz P; Ketteler M; Alscher MD; Schanz M
Kidney Blood Press Res; 2022; 47(2):125-134. PubMed ID: 34781282
[TBL] [Abstract][Full Text] [Related]
2. [High glucose dialysate enhances peritoneal fibrosis through upregulating glucose transporters GLUT1 and SGLT1].
Hong M; Nie Z; Chen Z; Yu X; Bao B
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 May; 45(6):598-606. PubMed ID: 28247603
[TBL] [Abstract][Full Text] [Related]
3. SGLT-2 inhibitors reduce glucose absorption from peritoneal dialysis solution by suppressing the activity of SGLT-2.
Zhou Y; Fan J; Zheng C; Yin P; Wu H; Li X; Luo N; Yu X; Chen C
Biomed Pharmacother; 2019 Jan; 109():1327-1338. PubMed ID: 30551383
[TBL] [Abstract][Full Text] [Related]
4. SGLT2 Inhibition by Intraperitoneal Dapagliflozin Mitigates Peritoneal Fibrosis and Ultrafiltration Failure in a Mouse Model of Chronic Peritoneal Exposure to High-Glucose Dialysate.
Balzer MS; Rong S; Nordlohne J; Zemtsovski JD; Schmidt S; Stapel B; Bartosova M; von Vietinghoff S; Haller H; Schmitt CP; Shushakova N
Biomolecules; 2020 Nov; 10(11):. PubMed ID: 33228017
[TBL] [Abstract][Full Text] [Related]
5. Recent Understanding of Peritoneal Pathology in Peritoneal Dialysis Patients in Japan.
Hamada C; Tomino Y
Blood Purif; 2021; 50(6):719-728. PubMed ID: 33567422
[TBL] [Abstract][Full Text] [Related]
6. Periostin: a matricellular protein involved in peritoneal injury during peritoneal dialysis.
Braun N; Sen K; Alscher MD; Fritz P; Kimmel M; Morelle J; Goffin E; Jörres A; Wüthrich RP; Cohen CD; Segerer S
Perit Dial Int; 2013; 33(5):515-28. PubMed ID: 23378472
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional patterns in peritoneal tissue of encapsulating peritoneal sclerosis, a complication of chronic peritoneal dialysis.
Reimold FR; Braun N; Zsengellér ZK; Stillman IE; Karumanchi SA; Toka HR; Latus J; Fritz P; Biegger D; Segerer S; Alscher MD; Bhasin MK; Alper SL
PLoS One; 2013; 8(2):e56389. PubMed ID: 23418565
[TBL] [Abstract][Full Text] [Related]
8. Peritoneal inflammation precedes encapsulating peritoneal sclerosis: results from the GLOBAL Fluid Study.
Lambie MR; Chess J; Summers AM; Williams PF; Topley N; Davies SJ;
Nephrol Dial Transplant; 2016 Mar; 31(3):480-6. PubMed ID: 26908833
[TBL] [Abstract][Full Text] [Related]
9. Accumulation of advanced glycation end products and beta 2-microglobulin in fibrotic thickening of the peritoneum in long-term peritoneal dialysis patients.
Nakamoto H; Hamada C; Shimaoka T; Sekiguchi Y; Io H; Kaneko K; Horikoshi S; Tomino Y
J Artif Organs; 2014 Mar; 17(1):60-8. PubMed ID: 24337623
[TBL] [Abstract][Full Text] [Related]
10. The peritoneal sieving of sodium: a simple and powerful test to rule out the onset of encapsulating peritoneal sclerosis in patients undergoing peritoneal dialysis.
La Milia V; Longhi S; Sironi E; Pontoriero G
J Nephrol; 2018 Feb; 31(1):137-145. PubMed ID: 28012100
[TBL] [Abstract][Full Text] [Related]
11. Regulation of glucose transporters in human peritoneal mesothelial cells.
Fischereder M; Schröppel B; Wiese P; Fink M; Banas B; Schmidbauer S; Schlöndorff D
J Nephrol; 2003; 16(1):103-9. PubMed ID: 12649541
[TBL] [Abstract][Full Text] [Related]
12. Expression of glucose transporters in human peritoneal mesothelial cells.
Schröppel B; Fischereder M; Wiese P; Segerer S; Huber S; Kretzler M; Heiss P; Sitter T; Schlöndorff D
Kidney Int; 1998 May; 53(5):1278-87. PubMed ID: 9573543
[TBL] [Abstract][Full Text] [Related]
13. Encapsulating Peritoneal Sclerosis.
Alston H; Fan S; Nakayama M
Semin Nephrol; 2017 Jan; 37(1):93-102. PubMed ID: 28153198
[TBL] [Abstract][Full Text] [Related]
14. Vasculopathy plays an important role during the development and relapse of encapsulating peritoneal sclerosis with conventional peritoneal dialysis solutions.
Tawada M; Ito Y; Banshodani M; Yamashita M; Shintaku S; Sun T; Suzuki Y; Kinashi H; Kubo Y; Ando M; Yamaguchi M; Katsuno T; Mizuno M; Kawanishi H
Nephrol Dial Transplant; 2021 Jul; 36(8):1519-1526. PubMed ID: 32437531
[TBL] [Abstract][Full Text] [Related]
15. Blockade of sodium-glucose co-transporters improves peritoneal ultrafiltration in uraemic rodent models.
Vorobiov M; Rogachev B; Riff R; Chaimowitz C; Neulander EZ; Basok A; Shnaider A; Douvdevani A; Haviv YS
Perit Dial Int; 2024 Jan; 44(1):48-55. PubMed ID: 37131323
[TBL] [Abstract][Full Text] [Related]
16. CD147 expression in peritoneal injury.
Seeger H; Latus J; Kitterer D; Alscher MD; Biegger D; Chen J; Edenhofer I; Wüthrich RP; Segerer S
Clin Exp Nephrol; 2017 Dec; 21(6):1097-1104. PubMed ID: 28551820
[TBL] [Abstract][Full Text] [Related]
17. Morphologic characteristics of macroscopic peritoneal finding in patients with peritoneal dialysis.
Hamada C; Nakamoto H; Suzuki Y
J Artif Organs; 2018 Mar; 21(1):102-109. PubMed ID: 28988370
[TBL] [Abstract][Full Text] [Related]
18. Complement system activation and peritoneal membrane alterations: Culprit or innocent bystander?
Borceux P; Morelle J; Goffin E
Perit Dial Int; 2020 Mar; 40(2):115-123. PubMed ID: 32063185
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the expression and spatial localization of glucose transporters in the rat, bovine and human lens.
Lim JC; Perwick RD; Li B; Donaldson PJ
Exp Eye Res; 2017 Aug; 161():193-204. PubMed ID: 28625822
[TBL] [Abstract][Full Text] [Related]
20. Encapsulating Peritoneal Sclerosis in Peritoneal Dialysis Patients After Kidney Transplantation.
Ayar Y; Ersoy A; Ocakoglu G; Gullulu E; Kagızmanlı H; Yıldız A; Oruc A; Yavuz M; Gullulu M; Dilek K
Transplant Proc; 2018; 50(1):160-164. PubMed ID: 29407302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
